FDA
-
-
-
-
-
-
-
DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors
-
-
-
-
-
-
-
DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada
-
-
-
-
-
-
-
DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology
-
-
-
-
-
-
-
DIAGNOS Announces a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico
-
-
-
-
-
-
-
DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE.
-
-
-
-
-
-
-
DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
-
-
-
-
-
-
327,061 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

